Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Why do challenging tasks make consumers believe drugs wear off faster?

  • Empathy or justice: What makes consumers donate more to charity?

  • I?ll have what he's having? How consumers make choices about new products

  • Retail pricing strategies: Do consumers prefer Deep Discounts or Everyday Low Prices?

  • Clients of violence interventional advocacy program find experience supportive

  • Potential Genetic Link Between Epilepsy, Neurodegenerative Disorders

  • Lacking trust in one's doctor affects health of emotionally vulnerable cancer patients

  • Dopamine transporter: Stampede supercomputer used to study common link between addiction, neurological disease

  • Should you should talk to strangers? Doing so increases positive experience, study shows

  • Genetic dysfunction connected to hydrocephalus discovered by international research team

  •